Chongqing Chunrui Medical and Chemical Co., Ltd., first restructured from Luoqi .As an enterprise integrating R&D, production and sales of fine chemicals and pharmaceutical intermediates, Chunrui is R&D base and production base of featured APIs and innovative products for Sansheng Shares.
The products of Chunrui include procaine hydrochloride, cefoxitin intermediate, chloramphenicol intermediate, chloramphenicol (API), aztreonam intermediate, orlistat intermediate and folic acid. Meanwhile, the company cooperates with world’s top 500 enterprises to produce intermediates for anti-AIDS drugs, anti-diabetes drugs and anti-hepatitis C drugs. The quality standard of its main products such as procaine hydrochloride, cefoxitin acid intermediate, chloramphenicol intermediate and chloramphenicol has reached the high standard worldwide. Among its products, procaine hydrochloride has been awarded the title of Chongqing Hi-tech Product and has been registered in Europe, India and so on. Chloramphenicol intermediate has passed FDA inspection in 2014.
With import-export right, Chunrui exports its products to India, Southeast Asia, Russia, South America and other overseas markets.
Year of Establishment:
2003
Total Assets(USD):
choose not to disclose
Total Number of Staff:
less than 10 person
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
R&D capacity:
Annual Turnover(USD):
choose not to disclose
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Other Competitive Advantages:
Patents and Copyrights:
Three years of qualification
Audited Supplier
Pharma Sources Insight JANUARY 2024
